ask="N/A"
ask_size="N/A"
average_daily_volume="967103"
bid="N/A"
bid_size="N/A"
book_value="-0.1530"
change="+0.0072"
change_from_200_day_moving_average="-0.1151"
change_from_50_day_moving_average="0.0239"
change_from_52_week_high="-1.4341"
change_From_52_week_low="0.2179"
change_in_percent="+1.8059%"
close="0.4059"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6540"
ebitda="-18.11M"
eps_estimate_current_year="-0.5900"
eps_estimate_next_quarter="-0.0900"
eps_estimate_next_year="-0.4500"
ex_dividend_date="N/A"
float_shares="43543000"
high="0.4200"
high_52_weeks="1.8400"
last_trade_date="1/10/2017"
last_trade_price="0.4059"
last_trade_size="300"
last_trade_time="4:02pm"
low="0.3703"
low_52_weeks="0.1880"
market_capitalization="27.49M"
moving_average_200_day="0.5210"
moving_average_50_day="0.3820"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.0000"
open="0.4200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-22.0954%"
percent_change_from_50_day_moving_average="+6.2565%"
percent_change_from_52_week_high="-77.9402%"
percent_change_from_52_week_low="+115.9043%"
previous_close="0.3987"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="224.9983"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="0.3600"
stock_exchange="ASE"
symbol="BPMX"
volume="667298"
weeks_range_52="0.1880 - 1.8400"
